TY - JOUR
T1 - Evaluation of Insecticide Resistance in Aedes albopictus (Diptera: Culicidae) in North Carolina, 2017
AU - Richards, Stephanie L.
AU - White, Avian V.
AU - Byrd, Brian D.
AU - Reiskind, Michael H.
AU - Doyle, Michael S.
N1 - Funding Information:
We thank the following counties in North Carolina (mosquito control personnel) for contributing mosquito eggs for the study: Buncombe (C. Ernst), Brunswick (J. Brown), Mecklenburg (J. Bjorneboe), New Hanover (M. Hemmen), Pitt (J. Gardner), Transylvania (N. Cagle), Wake (A. Figurskey). We also thank the following companies (personnel) for providing the FPs used in the bioassays: Adapco (S. Molnar), AMVAC (P. Connelly), Bayer (K. Vandock), Clarke (J. Strickhouser), FMC (D. Power). We thank J. Hooten, H. Knecht, A. Parale, M. Rawson, and M. Rhyne for their help with lab work. This study was funded by an North Carolina Department of Health and Human Services (NC DHHS) subcontract (Prime: CDC Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement [PI: Jean-Marie Maillard] to ECU and through NC DHHS AA908 assistance to local Health Departments (Larry Michael, NC DHHS Environmental Health Section). We thank two anonymous reviewers and the subject editor that provided thoughtful comments to improve the manuscript.
Publisher Copyright:
© The Author(s) 2018. Published by Oxford University Press on behalf of Entomological Society of America. All rights reserved.
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Mosquitoes may develop resistance to insecticide active ingredients (AIs) found in formulated products (FPs) due to environmental exposure from insecticides in mosquito control and/or unrelated to mosquito control, e.g., agricultural, household pest control. Mosquito control programs should implement resistance management strategies by assessing resistance in targeted populations, rotating different classes of insecticides based on resistance testing, and/or increasing insecticide concentration (i.e., saturation, using maximum labeled rate) to overcome emerging resistance. Resistance testing is often done solely on AIs, but should, in some cases, include both AIs and FPs at the concentrations mosquitoes may encounter in the field.The resistance/susceptibility status was determined for adulticides used in mosquito control. Centers for Disease Control and Prevention (CDC) bottle bioassays were used to assess resistance/susceptibility status for eight AIs (i.e., bifenthrin, permethrin, sumethrin/ prallethrin, deltamethrin, tau-fluvalinate, chlorpyrifos, malathion, and naled) and eight FPs (TalStar, Biomist 3 + 15, Duet, Suspend Polyzone, Mavrik, MosquitoMist, Fyfanon, and Dibrom) that respectively contain the AIs. Current CDC guidelines were utilized: susceptible (97–100% mortality at diagnostic time [DT]), developing resistance (90–96% mortality at DT), or resistant (<90% mortality at DT). Significant differences were observed in mosquito susceptibility/resistance among and between AIs and FPs.
AB - Mosquitoes may develop resistance to insecticide active ingredients (AIs) found in formulated products (FPs) due to environmental exposure from insecticides in mosquito control and/or unrelated to mosquito control, e.g., agricultural, household pest control. Mosquito control programs should implement resistance management strategies by assessing resistance in targeted populations, rotating different classes of insecticides based on resistance testing, and/or increasing insecticide concentration (i.e., saturation, using maximum labeled rate) to overcome emerging resistance. Resistance testing is often done solely on AIs, but should, in some cases, include both AIs and FPs at the concentrations mosquitoes may encounter in the field.The resistance/susceptibility status was determined for adulticides used in mosquito control. Centers for Disease Control and Prevention (CDC) bottle bioassays were used to assess resistance/susceptibility status for eight AIs (i.e., bifenthrin, permethrin, sumethrin/ prallethrin, deltamethrin, tau-fluvalinate, chlorpyrifos, malathion, and naled) and eight FPs (TalStar, Biomist 3 + 15, Duet, Suspend Polyzone, Mavrik, MosquitoMist, Fyfanon, and Dibrom) that respectively contain the AIs. Current CDC guidelines were utilized: susceptible (97–100% mortality at diagnostic time [DT]), developing resistance (90–96% mortality at DT), or resistant (<90% mortality at DT). Significant differences were observed in mosquito susceptibility/resistance among and between AIs and FPs.
KW - Active ingredient
KW - CDC bottle bioassay
KW - Formulated product
KW - Organophosphate
KW - Pyrethroid
UR - http://www.scopus.com/inward/record.url?scp=85064965349&partnerID=8YFLogxK
U2 - 10.1093/jme/tjy216
DO - 10.1093/jme/tjy216
M3 - Article
C2 - 30561686
AN - SCOPUS:85064965349
SN - 0022-2585
VL - 56
SP - 761
EP - 773
JO - Journal of Medical Entomology
JF - Journal of Medical Entomology
IS - 3
ER -